Brief: Amicus Therapeutics Enters License Agreement With Teva Pharmaceuticals

Amicus Therapeutics

17/10/2024 12:26

Oct 17 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS ANNOUNCES SETTLEMENT OF GALAFOLD®
(MIGALASTAT) PATENT LITIGATION WITH TEVA
    * AMICUS THERAPEUTICS INC - ENTERS LICENSE AGREEMENT WITH
TEVA
PHARMACEUTICALS
    * AMICUS THERAPEUTICS INC - TEVA TO MARKET GENERIC GALAFOLD
IN
U.S. STARTING JAN 30, 2037
    * AMICUS THERAPEUTICS - AMICUS WILL GRANT TEVA LICENSE TO
MARKET
GENERIC GALAFOLD IN U.S. STARTING JAN 30, 2037, IF APPROVED BY
FDA
    * AMICUS THERAPEUTICS INC - LITIGATION CONTINUES AGAINST
AUROBINDO, STAY REMAINS FOR LUPIN

Source text for Eikon:  ID:nGNX4c6x6Q 
Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))